CELU
Celularity Inc
NASDAQ: CELU · HEALTHCARE · BIOTECHNOLOGY
$0.93
-2.68% today
Updated 2026-04-30
Market cap
$32.01M
P/E ratio
—
P/S ratio
0.79x
EPS (TTM)
$-3.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Celularity Inc (CELU) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |